Da-Yong Lu - Concepedia

Author

Da-Yong Lu

Shanghai University ORCID

Also Known As

D Lu, D Y Lu, D. Lu, D.Y. LU, D.Y. Lu, Da Lu, Da Lü, Da Y. Lu, Da Yong Lu, Da Yong Lu

203

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Shanghai University Chinese Academy of Sciences Shanghai Institute of Materia Medica City University of New York Zhejiang University

About

Da-Yong Lu is an author at Shanghai University specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	383
2	Health Sciences	4	4	96
3	Engineering	2	2	108
4	Social Sciences	2	2	23
5	Natural Sciences	1	1	17

Da-Yong Lu

Publications

784

Citations

H-Index

Page 1

	Year	Citations
Analysis of Flavonoids from Leaves of Cultivated Lycium barbarum L. Jing Dong, Da-Yong Lu, Yan Wang Plant Foods for Human Nutrition EngineeringBotanyPlant MetabolomicsPlant PathologyPhytochemistry	2009	81
Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination – An effective strategy to improve clinical treatment Da-Yong Lu, Xue Liang Chen, Jian Ding Medical Hypotheses Systems PharmacologyComputational CoordinationOncologyTumor HeterogeneityMedicine	2005	52
Cancer Metastasis Treatments Da-Yong Lu, Ting-Ren Lu, Hongying Wu, Current Drug Therapy	2013	46
Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines Da-Yong Lu, Min Huang, Cheng Xu, BMC Pharmacology	2005	42
Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications Swathi Putta, Ilaria Peluso, Nagendra Sastry Yarla, Current Pharmaceutical Design AgingErectile DysfunctionMetabolic SyndromeLongevityHealth Sciences	2017	33
Individualized Cancer Therapy, Future Approaches Da-Yong Lu, Ting-Ren Lu, Bin Xu, Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine	2018	33
Anticancer Drug Combinations, How Far We can Go Through? Da-Yong Lu, Enhong Chen, Hongying Wu, Anti-Cancer Agents in Medicinal Chemistry Anticancer Drug CocktailAnticancer Drug CombinationsChemoprevention StrategyPathologyPharmacotherapy	2017	32
Cancer Metastases and Clinical Therapies Da-Yong Lu, Ting-Ren Lu Cell & Developmental Biology Cancer TherapeuticsHealth SciencesMedicineImmunologyTumor Immunity	2012	31
Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy Da-Yong Lu, Xue Liang Chen, Jian Ding Medical Hypotheses Drug TargetingOncologyNovel TherapySolid TumorsMedicine	2006	30
Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids Da-Yong Lu Scientia Pharmaceutica Tumor BiologyTherapeutic BenefitsTumor Sialic AcidsOncologyDrug Targeting	2012	29

Page 1